Temple R C, Carrington C A, Luzio S D, Owens D R, Schneider A E, Sobey W J, Hales C N
Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge.
Lancet. 1989 Feb 11;1(8633):293-5. doi: 10.1016/s0140-6736(89)91306-8.
A highly specific two-site immunoradiometric assay for insulin was used to measure the plasma insulin response to 75 g glucose administered orally to 49 patients with non-insulin-dependent diabetes (NIDDM). The plasma insulin concentration 30 min after glucose ingestion was lower in the diabetic patients than in matched controls for both non-obese (11-83 pmol/l vs 136-297 pmol/l, p less than 0.01) and obese subjects (23-119 pmol/l vs 137-378 pmol/l, p less than 0.01). By means of another two-site immunoradiometric assay, the basal intact proinsulin level was found to be higher in the NIDDM patients than in the controls for both non-obese (7.1 [SEM 1.2] pmol/l vs 2.4 [0.4] pmol/l, p less than 0.01) and obese subjects (14.4 [2.2] pmol/l vs 5.9 [1.9] pmol/l, p less than 0.01). The basal level of 32-33 split proinsulin was also raised in NIDDM. Previous failure to show clear separation between normal and NIDDM insulin responses was probably due to the high concentrations of proinsulin-like molecules in the plasma of NIDDM patients. These substances cross-react as insulin in most, if not all, insulin radioimmunoassays but have very little biological insulin-like activity. It is therefore now possible and necessary to designate most NIDDM patients as insulin deficient.
采用一种高度特异的胰岛素双位点免疫放射分析方法,对49例非胰岛素依赖型糖尿病(NIDDM)患者口服75克葡萄糖后的血浆胰岛素反应进行了测定。无论是非肥胖患者(摄入葡萄糖后30分钟时血浆胰岛素浓度为11 - 83 pmol/L,而匹配对照组为136 - 297 pmol/L,p < 0.01)还是肥胖患者(23 - 119 pmol/L 对 137 - 378 pmol/L,p < 0.01),糖尿病患者摄入葡萄糖后30分钟时的血浆胰岛素浓度均低于匹配对照组。通过另一种双位点免疫放射分析方法发现,无论是非肥胖患者(7.1 [标准误1.2] pmol/L 对 2.4 [0.4] pmol/L,p < 0.01)还是肥胖患者(14.4 [2.2] pmol/L 对 5.9 [1.9] pmol/L,p < 0.01),NIDDM患者的基础完整胰岛素原水平均高于对照组。NIDDM患者的32 - 33裂解胰岛素原基础水平也有所升高。以往未能明确区分正常人和NIDDM患者胰岛素反应,可能是由于NIDDM患者血浆中胰岛素原样分子浓度较高。这些物质在大多数(即便不是全部)胰岛素放射免疫分析中会与胰岛素发生交叉反应,但几乎没有生物学胰岛素样活性。因此,现在有可能且有必要将大多数NIDDM患者认定为胰岛素缺乏。